1. Anti-HIV-1 Activity and Mode of Action of a Viral-derived and Proteolysis-resistant Peptide CXCR4 Antagonist. Cadima-Couto, I., A. Tauzin, J.M. Freire, T.N. Figueira, R.D.M. Silva, C. Perez-Peinado, C. Cunha-Santos, I. Bartolo, N. Taveira, L. Gano, J.D.G. Correia, J. Goncalves, F. Mammano, D. Andreu, M. Castanho, and A.S. Veiga. FEBS Open Bio, 2021. 11: p. 314-314. ISI[000668898601325].
[WOS]. HIV_08_2021.
2. Design and Synthesis of Quinolizidine Derivatives as Influenza Virus and HIV-1 Inhibitors. Dang, Z., L. Zhu, L. Xie, K.H. Lee, F. Malik, Z. Li, L. Huang, and C.H. Chen. Current Medicinal Chemistry, 2021. 28(24): p. 4995-5003. PMID[33372864].
[PubMed]. HIV_08_2021.
3. LEDGINs, Inhibitors of the Interaction between HIV-1 Integrase and LEDGF/P75, Are Potent Antivirals with a Potential to Cure HIV Infection. Debyser, Z., A. Bruggemans, S. Van Belle, J. Janssens, and F. Christ. Advances in Experimental Medicine and Biology, 2021. 1322: p. 97-114. PMID[34258738].
[PubMed]. HIV_08_2021.
4. Blocking α(4)β(7) Integrin Delays Viral Rebound in SHIV(SF162P3)-Infected Macaques Treated with Anti-HIV Broadly Neutralizing Antibodies. Frank, I., M. Cigoli, M.S. Arif, M.D. Fahlberg, S. Maldonado, G. Calenda, A. Pegu, E.S. Yang, R. Rawi, G.Y. Chuang, H. Geng, C. Liu, T. Zhou, P.D. Kwong, J. Arthos, C. Cicala, B.F. Grasperge, J.L. Blanchard, A. Gettie, C.M. Fennessey, B.F. Keele, M. Vaccari, T.J. Hope, A.S. Fauci, J.R. Mascola, and E. Martinelli. Science Translational Medicine, 2021. 13(607): eabf7201. PMID[34408080].
[PubMed]. HIV_08_2021.
5. Chemical Characterization and anti-HIV-1 Activity Assessment of Iridoids and Flavonols from Scrophularia trifoliata. Guzzo, F., R. Russo, C. Sanna, O. Celaj, A. Caredda, A. Corona, E. Tramontano, A. Fiorentino, F. Esposito, and B. D'Abrosca. Molecules, 2021. 26(16): 4777. PMID[34443358]. PMCID[PMC8398805].
[PubMed]. HIV_08_2021.
6. Accessing HIV-1 Protease Inhibitors through Visible-light-mediated Sequential Photocatalytic Decarboxylative Radical Conjugate addition-elimination-oxa-Michael Reactions. Krolo, T., A. Bhattacharyya, and O. Reiser. Organic Letters, 2021. 23(16): p. 6283-6287. PMID[34347496].
[PubMed]. HIV_08_2021.
7. Anti-HIV Effects of Baculiferins Are Regulated by the Potential Target Protein DARS. Liu, J., L. Ma, C. Song, H. Xing, S. Cen, and W. Lin. ACS Chemical Biology, 2021. 16(8): p. 1377-1389. PMID[34338505].
[PubMed]. HIV_08_2021.
8. Bispecific Anti-HIV Immunoadhesins That Bind Gp120 and Gp41 Have Broad and Potent HIV-neutralizing Activity. Pincus, S.H., R.B. Craig, L. Weachter, C.C. LaBranche, R. Nabi, C. Watt, M. Raymond, T. Peters, K. Song, G.A. Maresh, D.C. Montefiori, and P.A. Kozlowski. Vaccines, 2021. 9(7): 774. PMID[34358190]. PMCID[PMC8310024].
[PubMed]. HIV_08_2021.
9. Bioactive Compounds from Euphorbia usambarica Pax. With HIV-1 Latency Reversal Activity. Tsai, Y.C., R.A. Nell, J.E. Buckendorf, N. Kúsz, P.W. Mwangi, R. Berkecz, D. Rédei, A. Vasas, A.M. Spivak, and J. Hohmann. Pharmaceuticals, 2021. 14(7): 653. PMID[34358079]. PMCID[PMC8308672].
[PubMed]. HIV_08_2021.
10. IP-10 Promotes Latent HIV Infection in Resting Memory CD4(+) T Cells via LIMK-Cofilin Pathway. Wang, Z., X. Yin, M. Ma, H. Ge, B. Lang, H. Sun, S. He, Y. Fu, Y. Sun, X. Yu, Z. Zhang, H. Cui, X. Han, J. Xu, H. Ding, Z. Chu, H. Shang, Y. Wu, and Y. Jiang. Frontiers in Immunology, 2021. 12: 656663. PMID[34447368]. PMCID[PMC8383741].
[PubMed]. HIV_08_2021.
11. Discovery of Macrocyclic HDACs 1, 2, and 3 Selective Inhibitors for HIV Latency Reactivation. Yu, W., J. Fells, D. Clausen, J. Liu, D.J. Klein, C. Christine Chung, R.W. Myers, J. Wu, G. Wu, B.J. Howell, R.J.O. Barnard, and J. Kozlowski. Bioorganic & Medicinal Chemistry Letters, 2021. 47: 128168. PMID[34091041].
[PubMed]. HIV_08_2021.
Patent Citations
12. Novel Triterpene Derivatives as HIV Inhibitors. Bandi, P.R., R.R. Kura, P.R. Adulla, and B.R. Kasireddy. Patent. 2021. 2021-IB51116 2021161206: 104pp.
[Patent]. HIV_08_2021.